Revvity Expands Alliance with Genomics England to Drive Research into Newborn Genomic Sequencing in England
Revvity, Inc. (RVTY)
Company Research
Source: Business Wire
New agreement to support newborn health adds sequencing lab services to the existing extraction services collaboration WALTHAM, Mass.--(BUSINESS WIRE)--Revvity, Inc. (NYSE: RVTY) today announced an agreement with Genomics England to further collaborate on the Generation Study. Under the new contract, Revvity will now also provide DNA sequencing services to help screen newborns for rare genetic conditions. This expanded relationship builds upon the previously disclosed agreement to perform DNA extraction services. Revvity will now be able to provide an integrated end-to-end solution with a localized lab facility, which will allow for accelerated extraction and sequencing services to advance the screening process for these rare conditions.The Generation Study, a research project spearheaded by Genomics England in partnership with the National Health Service, is a landmark national initiative aimed at screening up to 100,000 newborns for more than 200 rare genetic disorders. The findi
Show less
Read more
Impact Snapshot
Event Time:
RVTY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
RVTY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
RVTY alerts
High impacting Revvity, Inc. news events
Weekly update
A roundup of the hottest topics
RVTY
News
- Revvity to Present at J.P. Morgan Healthcare ConferenceBusiness Wire
- Revvity Introduces Signals Xynthetica, an AI-Augmented Design Platform for Molecular and Materials DiscoveryBusiness Wire
- Revvity (NYSE:RVTY) was downgraded by analysts at Bank of America Corporation from a "buy" rating to a "neutral" rating. They now have a $110.00 price target on the stock.MarketBeat
- Revvity (NYSE:RVTY) was given a new $107.00 price target on by analysts at Wells Fargo & Company.MarketBeat
- Revvity (NYSE:RVTY) had its "overweight" rating reaffirmed by analysts at Barclays PLC.MarketBeat
RVTY
Earnings
- 10/27/25 - Beat
RVTY
Sec Filings
- 12/18/25 - Form 4
- 12/17/25 - Form 4
- 11/18/25 - Form NPORT-P
- RVTY's page on the SEC website